164 related articles for article (PubMed ID: 26318425)
1. RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.
Qin Y; Chen W; Xiao Y; Yu W; Cai X; Dai M; Xu T; Huang W; Guo W; Deng W; Wu T
Oncotarget; 2015 Sep; 6(29):27130-45. PubMed ID: 26318425
[TBL] [Abstract][Full Text] [Related]
2. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
Chen W; Lu J; Qin Y; Wang J; Tian Y; Shi D; Wang S; Xiao Y; Dai M; Liu L; Wei G; Wu T; Jin B; Xiao X; Kang TB; Huang W; Deng W
Oncotarget; 2014 Dec; 5(23):11909-23. PubMed ID: 25481043
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
Guo W; Lu J; Dai M; Wu T; Yu Z; Wang J; Chen W; Shi D; Yu W; Xiao Y; Yi C; Tang Z; Xu T; Xiao X; Yuan Y; Liu Q; Du G; Deng W
Oncotarget; 2014 Oct; 5(19):9349-61. PubMed ID: 25294805
[TBL] [Abstract][Full Text] [Related]
4. Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation.
Zohud BA; Guo P; Zohud BA; Li F; Hao JJ; Shan X; Yu W; Guo W; Qin Y; Cai X
Cell Death Dis; 2020 Oct; 11(10):879. PubMed ID: 33082305
[TBL] [Abstract][Full Text] [Related]
5. EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non‑small cell lung cancer cells.
Lin C; Qin Y; Zhang H; Gao MY; Wang YF
Oncol Rep; 2018 Jul; 40(1):29-38. PubMed ID: 29749533
[TBL] [Abstract][Full Text] [Related]
6. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
Tang Z; Yu W; Zhang C; Zhao S; Yu Z; Xiao X; Tang R; Xuan Y; Yang W; Hao J; Xu T; Zhang Q; Huang W; Deng W; Guo W
Mol Oncol; 2016 Feb; 10(2):317-29. PubMed ID: 26628108
[TBL] [Abstract][Full Text] [Related]
7. KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
Hu W; Jia Y; Xiao X; Lv K; Chen Y; Wang L; Luo X; Liu T; Li W; Li Y; Zhang C; Yu Z; Huang W; Sun B; Deng WG
Oncotarget; 2016 Aug; 7(33):52870-52887. PubMed ID: 27153563
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
9. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
12. Ku80 cooperates with CBP to promote COX-2 expression and tumor growth.
Xiao Y; Wang J; Qin Y; Xuan Y; Jia Y; Hu W; Yu W; Dai M; Li Z; Yi C; Zhao S; Li M; Du S; Cheng W; Xiao X; Chen Y; Wu T; Meng S; Yuan Y; Liu Q; Huang W; Guo W; Wang S; Deng W
Oncotarget; 2015 Apr; 6(10):8046-61. PubMed ID: 25797267
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
14. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
16.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
17. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
Yang JH; Li XY; Wang X; Hou WJ; Qiu XS; Wang EH; Wu GP
PLoS One; 2017; 12(8):e0182775. PubMed ID: 28813465
[TBL] [Abstract][Full Text] [Related]
18. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
19. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
